smNopsis The current state of knowledge on the biochemical abnormalities in the mucopolysaccharidoses is reviewed. Methods for the estimation and identification of glycosaminoglycans excreted in the mucopolysaccharidoses are discussed and a selection of simple and reliable methods of value in a small hospital laboratory have been given in detail in an appendix.
A review and selection of simple laboratory methods used for the study of glycosaminoglycan excretion and the diagnosis of the mucopolysaccharidoses C. A. PENNOCK From the Department of Child Health, University of Bristol smNopsis The current state of knowledge on the biochemical abnormalities in the mucopolysaccharidoses is reviewed. Methods for the estimation and identification of glycosaminoglycans excreted in the mucopolysaccharidoses are discussed and a selection of simple and reliable methods of value in a small hospital laboratory have been given in detail in an appendix.
The mucopolysaccharidoses are a rare group of inherited disorders of connective tissue metabolism of which the condition most familiar to clinicians is Hurler's syndrome (previously given the unpleasant name 'gargoylism' due to the unusual facial appearance). The clinical features have been reviewed by McKusick and others (McKusick et al, 1965; McKusick, 1969 McKusick, , 1972 . These disorders have long been known to be associated with excessive mucopolysaccharide excretion (Dorfman and Lorincz, 1957; Meyer et al, 1958) . The term mucopolysaccharide, although still retained in medical literature, does lead to confusion between polysaccharides containing both hexosamines and hexuronic acids and a variety of mucins and other mucosubstances which do not contain hexuronic acids. Jeanloz (1960) introduced the term glycosaminoglycuronans (GAG) for the acidic polysaccharides only, and the current nomenclature and suitable abbreviations for these compounds are given in table I. Knowledge of the detailed structure of these compounds has been reviewed by Muir (1969) and Dorfman and Matalon (1972) and is sununarized in table II. The amino sugar residues may be N-acetylated, N-sulphated or 0-sulphated at carbon 4 or carbon 6. In the interests of clarity, the trivial names of the residues will be used throughout the rest of this article, for example, 2-acetamido-2-deoxy-ot-D-glucopyranose will be referred to as N-acetylglucosamine.
In 1964 Van Hoof and Hers identified the mucopolysaccharidoses as lysosomal storage disorders by electron microscopy, and since that date it has become increasingly apparent that they are due to genetic defects in the synthesis and activity of Protein-polysaccharide complex Table I Current nomenclature based on the work of Jeanloz (1960) 'The term glycosaminoglycan is usually preferred in current literature since glycosaminoglycuronans contain hexuronic acids, and this term would not include the keratan sulphates which contain galactose instead of hexuronic acid residues.
enzymes essential for the degradation of connective tissue GAG. Fratantoni et al (1968a) incubated cultured fibroblasts from patients with mucopolysacchridoses, in the presence of 35S-labelled sulphate, and showed increased accumulation and delayed release of label in abnormal cells compared with normal controls and concluded that this indicated defective degradation of synthesized GAG. In the same year they (1968b) (1970, 1972) and Bach et al (1972) .
Recently, a number of specific enzyme defects have been identified and have led to a slight modification of the earlier classifications (McKusick, 1972 (Sly et al, 1973) and in the other DS excretion was elevated (Beaudet et al, 1972) .
by relating GAG excretion to creatinine excretion, and this may be done on random samples of urine collected from outpatients. Although creatinine excretion varies during a 24-hour period and the GAG/creatinine ratio is increased at night (Di Ferrante and Lipscomb, 1970) , the excretion of both substances remains fairly constant during waking hours (say 0900-1800 hours) and the GAG/creatinine ratios in samples obtained during this period are similar to those obtained on complete 24-hour urine collections . Infected samples should not be used, but some preservatives may interfere with the analyses, eg, thymol interferes with some screening tests and toluene lowers the efficiency of precipitation methods (Di Ferrante, 1967) . Their use is best avoided if possible, and the author prefers samples to be frozen solid as soon as possible after collection, and kept frozen during transport to the laboratory and while awaiting analysis. However, freezing is not essential, and adequate diagnostic information can be gained from the analysis of samples which have been sent through the post provided the sample is not infected. For postal delivery, the author requests three or more random samples of urine collected at different times; all non-infected samples can be pooled, and this usually gives enough material for a full qualitative analysis if necessary (see below).
Some urine samples may be very concentrated, which may lead to inadequate isolation of GAG and hence error in quantitative analyses (Di Ferrante, 1967) . The sample should be diluted with distilled water to lower the specific gravity to below 1020 before any tests, including estimation of creatinine, are done. Very dilute samples of low specific gravity and creatinine content should be discarded since small errors in the estimation of the latter may give false positive or false negative results.
Screening Tests
The main objectives in selecting any chemical screening test should be that the test (1) should never give a false negative result, (2) is easy and quick to perform, and (3) gives a minimum number of false positive results which would require further analysis. Although a large number of screening tests have been devised, the majority fail on at least one of these criteria, mainly because they take no account of urine concentration. If an identical volume of urine is used in each case, a concentrated urine from a normal individual may give a false positive result while a dilute urine from a patient with a mucopolysaccharidosis will give a false negative result.
Screening tests fall into two main categories, paper spot tests based on the interaction of urinary GAG with a suitable cationic dye, and precipitation tests based on the interaction of GAG with acidified albumin, quaternary ammonium compounds, or alcian blue.
Spot Tests
A number of paper spot tests have been described in which a fixed volume of urine is applied to filter paper, dried, and stained with a solution of suitable dye. The dyes used have included toluidine blue (Berry and Spinanger, 1960) , alcian blue (Carson and Neill, 1962; Procopsis et al, 1968) , and azur A (Berman et al, 1971) . None of these tests takes urine concentration or age-related changes in GAG excretion into account. Carter et al (1968) found 31-5 Y.
false negative results using toluidine blue to test 54 urine samples from patients with Hurler's syndrome, and Procopsis et al (1968) found a false negative result using alcian blue. Allowing for the urine concentration by spotting a urine volume containing a fixed amount of creatinine does not climinate false negative results. The method using azur A (Berman et al, 1971 ) was based on a study of only 17 samples. This test does not take urine concentration into account, and the recommended procedure seems unlikely to be an improvement on the other screening tests.
In view of the high incidence of false negative results, paper spot tests should not be used as screening tests for the mucopolysaccharidoses.
Precipitation Tests
The interaction of GAG with acidified bovine albumin to form a flocculent precipitate has also been used as a screening test (Dorfman, 1958; Denny and Dutton, 1962) . This test also does not take urine concentration into account, and false negative results have been found in three patients with Hurler's syndrome and three patients with Sanfilippo syndrome using the test in its original form . Even when refined by quantitative measurement of the turbidity (Steiness, 1961) false negative results have also been found in 9-2% of samples from patients with Hurler's syndrome (Carter et al, 1968) and in patients with Sanfilippo syndrome (Lewis et al, 1974) .
The observation that GAG will react with quaternary ammonium compounds to give a precipitate (Scott, 1960) has also been used as a screening test. Renuart (1966) added a buffered solution of cetyltrimetryl ammonium bromide (CTAB) to urine and observed a flocculent precipitate after 30 minutes in samples with high GAG content. In the author's experience this test is often difficult to interpret since normal urines frequently give a peculiar precipitate and a true flocculent precipitate is so rarely seen that it is difficult to explain to an inexperienced observer what to look for.
A semiquantitative test in which cetylpyridinium chloride (CPC) is added to urine and the turbidity recorded was described by Manley and Hawksworth (1966) . They found that timing was critical since aggregation of particles occurred after four minutes. They also found that results changed with age throughout childhood, but again this test does not take urine concentration into account.
Precipitation of GAG with CPC or CTAB is affected by ionic strength and pH (Scott, 1960) (Pennock, 1969) also overcomes the critical time dependence of the CPC test as described by Manley and Hawksworth (1966) . The inclusion of standards enables a quantitative result to be obtained. It is essential that allowance is made for urine concentration effects by relating the results to the creatinine content of the sample, and that it is appreciated that GAG excretion changes with age throughout childhood so that the correct normal range can be used (Pennock, 1969 (Pennock, 1973; B. Turner-personal communication). 7. The incidence of false positive results is acceptable; 5% in the first year of life and 2.6% in older children were found in one study of 3000 children ) and 3-6% in another study of 1000 children (Valdivieso et al, 1973) .
It is for these reasons that the CPC citrate test is given in more detail as the screening method of choice in the appendix.
Quantitative Estimtion of Urinary GAG
Quantitative estimation is based on measurement of hexuronic acid residues which all the GAG contain, except keratan sulphate. Separation of GAG from interfering substances has been achieved in a number of ways. Hexuronic acid may be measured on the dialysed sample directly (Segni et al, 1964; Rosenfeld, 1971) or after a further purification step, such as fractionation on ECTEOLA cellulose columns, which enables sulphated and non-sulphated GAG to be measured separately (Wessler, 1967; Blackham and Raine, 1970) , or by precipitation with CTAB or CPC (Thompson and Castor, 1966; Teller et al, 1962) or aminoacridine (Bitter et al, 1970; Dean et al, 1971) . CPC and CTAB are poor precipitants of GAG in the absence of salts, and it is preferable to use the method described by Di Ferrante and Rich (1956) in which these agents are added to untreated urine. CPC is the best of the three precipitants in the presence of urinary salts (Di Ferrante, 1967) although glycoproteins tend to be co-precipitated. The latter problem is easily overcome as a higher concentration of precipitant than recommended by Di Ferrante (1967) leaves glycoproteins in solution (Goldberg and Cotlier, 1972; Pennock, 1973) . Aminoacridine has not been widely used because, in addition to being less efficient than CPC, the method is more time consuming.
Column chromatography of either dialysed or CPC precipitated samples has held an important place in research into GAG excretion patterns but is time consuming and results in a large number of fractions for further analysis. However, the addition of urine directly to an ECTEOLA cellulose column and elution of GAG with a single solvent gives the same results as CPC precipitation (Di Ferrante, 1967) .
The amount of hexuronic acid containing material present after dialysis varies with the duration of dialysis, the number of changes of distilled water, and pore size of the membrane, and considerable losses of GAG may occur (Rosenfeld, 1971) . This applies particularly to samples from patients with Hurler's syndrome in which up to 50 % of the GAG may be dialysable compared with i1i% in samples from normal subjects (Constantopoulos, 1968) ; similar losses have been found in Scheie's syndrome even when Visking dialysis tubing was heated to reduce the pore size (Pennock, 1973) .
However, despite losses, the hexuronic acid content of a dialysed sample is usually, but not always, greater than that recovered by CPC precipitation of untreated urine. The CPC precipitable hexuronic acid was found by Rosenfeld (1971) to be 25-55 % of non-dialysable hexuronic acid in normal adults and 70% in children, and a similar range of 11-65 % in adults but a greater range of 71-156 % in children was found by Pennock et al (1975) , ie, in samples from some normal children a large portion of CPC precipitable material will be lost on dialysis. This has also been observed in some patients with mucopolysaccharidoses (see above). It is not known whether the high results in some dialysed samples are due to interfering chromogens, as suggested by Manley et al (1968) , or to the presence of GAG which is not CPC precipitable, as suggested by Rosenfeld (1971) . Rosenfeld (1971) has shown the presence of at least three GAG types and suggested the possibility of a fourth. GAG may be: (1) high molecular weight, non-dialysable but CPC precipitable; (2) low molecular weight, ultrafilterable, and thus lost on dialysis but CPC precipitable; (3) very low molecular weight, ultrafilterable and lost on dialysis, and not CPC precipitable; (4) low molecular weight and attached to proteins which are neither dialysable nor precipitable. Di Ferrante et al (1972) have confirmed that low molecular weight GAG exist which are not CPC precipitable and which will pass through a Visking dialysis membrane even after reduction of pore size with heat treatment. However, the actual concentration of these low molecular weight GAG in patients with mucopolysaccharidoses is the same as in normal children so that the estimation of this fraction is of little diagnostic value, although further research into their nature could be enlightening. It is important to emphasize that precipitation of GAG with CPC from untreated urine gives the same results as isolation by ECTEOLA cellulose chromatography. The former is the simpler of the two methods and is therefore described in the appendix. Because the proportion of CPC precipitable GAG which is lost on dialysis varies among normal individuals and patients with mucopolysaccharidoses one must reiterate the comment made by Di Ferrante (1967), 'One cannot be too emphatic in discouraging dialysis of urine prior to precipitation'.
Once a suitable GAG preparation has been isolated the estimation of hexuronic acid presents little problem and it may be measured by the carbazole-sulphuric acid method (Dische, 1947) or the borate modification of that method (Bitter and Muir, 1962) . The latter gives almost equal colour yield for glucuronic and iduronic acid and may be carried out as a single step reaction in the modified manner described in the appendix. Whiteman (1973a, b) has described a quantitative test in which GAG are precipitated with alcian blue and the dye is ultimately eluted from the precipitate and measured colorimetrically. This test may offer advantages over CPC precipitation in that the colour yield for equal amounts of different GAG is almost identical and keratan sulphate is precipitated. Results by this method tend to be slightly higher than those obtained by measuring CPC precipitable hexuronic acid, and this may be due to other unknown reactants but there is a reasonable correlation between the two methods (Whiteman, 1973b Identification of GAG excretion pattern requires simple methods for separating and assessing the relative proportions of heparan, dermatan, and keratan sulphates. Most investigations have used column chromatography but separations are often imperfect (Kaplan, 1969) . Full identification requires hydrolysis of the appropriate fractions and structural identification by defining the principal hexosamines (see table II) by further column chromatography which is not only time-consuming but often affords inadequate separation. These methods are quite unsuited to the small hospital laboratory.
Electrophoretic separation may be done in barbitone buffer (Manley and Hawksworth, 1966) . Although this method does not separate dermatan sulphate (DS) from the chondroitin sulphates (CS) nor heparan sulphate (HS) from keratan sulphate, it is a useful method since galactosamine containing GAG and glucosamine containing GAG migrate as two separate bands. Other separations have been described which are based on GAG structure and include electrophoresis in barium acetate (Wessler, 1968) in which keratan sulphate separates poorly from chondroitin sulphates, and electrophoresis in cupric acetate (Hata and Nagai, 1972) and zinc sulphate (Hardingham and Phelps, 1970) , both of which fail to separate heparan and keratan sulphates, and the poorly defined separations of other GAG are more difficult to interpret than those achieved in barbitone or barium acetate (Pennock, 1973) . Barium acetate gives good separation of DS and HS (Lewis et al, 1974) , and this method has been selected and described in the appendix because of its speed and simplicity.
Thin layer chromatography of GAG has been used by Wusteman et al (1966) who found difficulty in separating dermatan sulphate, and by Teller and Ziemann (1969) who were unable to separate keratan sulphate from other GAG. The best method described so far is that based on the relative solubility of different GAG, as their calcium salts, in alcohol using a sequence of solvents which affords a very rapid and efficient separation of all GAG (Lippiello and Mankin, 1971; Humbel and Chamoles, 1972) . The method is included in the appendix with comments on intepretation of patterns of GAG excretion. This is the only method which clearly separates keratan sulphate from other GAG and is thus invaluable in the diagnosis of Morquio's disease.
In summary, the simple tests required include: , estimation and identification of hexosamine content by gas liquid chromatography (Murphy et al, 1974) , specific estimation of dermatan sulphate (Di Ferrante et al, 1971) , estimation of amino sulphate as a measure of heparan sulphate (Lagunoff et al, 1967) or measurement of keratan sulphate as galactose (Robertson and Harvey, 1972 (Valdivieso et al, 1973) , malabsorption syndromes with gross osteomalacia, malignant disorders with extensive secondary deposits (including leukaemia), and patients with disseminated lupus erythematosus ; some patients with rheumatoid arthritis (Di Ferrante, 1957; Thompson and Castor, 1966) and some with Marfan's syndrome (Berenson and Dalferes, 1965; Bitter et al, 1970) as well as a few other rare disorders (Brimacombe and Stacey, 1964) . Qualitative examination of excreted GAG shows that chondroitin sulphates predominate and hence the excretion pattern is similar to normal excretion and easily differentiated from the pattern in the mucopolysaccharidoses.
Patients with one of the mucopolysaccharidoses excrete excessive amounts of heparan, dermatan or keratan sulphates, and the excretion patterns are shown in table IV. The excretion pattern in Hurler's, Scheie's, and Maroteaux-Lamy syndromes is consistent and easy to interpret. In a detailed study of excretion patterns, Kaplan (1969) found roughly equal amounts of heparan sulphate in patients with Hunter's syndrome. Others have failed to confirm this, finding that the pattern in Hunter's syndrome more frequently resembles the pattern in Hurler's syndrome (Maroteaux, 1970; Pennock, 1973) . Therefore, these two conditions cannot always be distinguished by the simple methods described. This does not detract from the value of the simple methods since distinction is also difficult to make using more sophisticated techniques, and furthermore the problem is not usually great since distinction between the two syndromes may be made on clinical grounds. Similar comments apply to Scheie's syndrome (MPS Type IS) where the enzyme defect and excretion pattern are identical with those of Hurler's syndrome (Wiesmann and Neufeld, 1970) but the clinical features are distinctly different (McKusick, 1972) In Sanfilippo syndrome, in which there are two different enzyme defects, there appear to be two patterns of heparan sulphate excretion which cannot group.bmj.com on June 19, 2017 -Published by http://jcp.bmj.com/ Downloaded from be distinguished by electrophoresis (Lewis et al, 1974) . However, by thin layer chromatography one type shows a heparan sulphate fraction which migrates in the same position as heparan sulphate from normal urine while the other type shows a heparan sulphate fraction which behaves as if it were chondroitin-4-sulphate. However, the pattern is still distinct from normal and gives no problem in interpretation if electrophoresis in barium acetate is also done when any doubt exists.
The diagnosis of Morquio's disease, although it is clearly a mucopolysaccharidosis with abnormal keratan sulphate metabolism (Robins et al, 1963) , should be regarded as a separate problem. This is mainly because keratan sulphate excretion may sometimes be normal, especially in adult life (Maroteaux and Lamy, 1967; Linker et al, 1970; Jenkins et al, 1973) . When keratan sulphate excretion is increased the CPC citrate screening test is usually positive and usually there is also an increase in CPC precipitable hexuronic acid since there is a parallel increase in chondroitin sulphate excretion (Pennock, 1973) . Although it has been disputed that keratan sulphate is precipitated by CPC, it is now clear that although precipitation is difficult from aqueous solutions it is readily achieved in urine (Di Ferrante, 1967) . Indeed the first demonstration of increased keratan sulphate excretion in Morquio's disease by Pedrini et al (1962) was achieved using quatemary ammonium precipitants. Furthermore, it seems likely that most of the keratan sulphate is actually excreted as a complex with chondroitin sulphate similar to the form in which it exists in cartilage although probably of reduced molecular size. Since it is only soluble in excess CPC when it is totally released from its hybrid chondroitin sulphate complex (Goldberg, 1973; Kaplan et al, 1968) , most urinary keratan sulphate would precipitate with the chondroitin sulphate fraction. Recently the excretion of keratan sulphate throughout childhood has been studied by Robertson and Harvey (1972) , using ion-exchange chromatography followed by GAG precipitation and estimation of keratan sulphate as galactose. This is a potentially useful method for the study of Morquio's disease and other spondyloepiphyseal dysplasias. This disease clearly requires further study, and its separation from the other mucopolysaccharidoses in this sense appears justified.
One final problem is worthy of mention. It is often difficult to distinguish high abnormal GAG excretion from normal results in the neonatal period since GAG excretion in relation to creatinine is high at this time of life even in normal individuals (Pennock et al, 1971) . A request for examination of urinary GAG in the first year of life should, therefore, be 2 completed by qualitativeexaminationof the excretion pattern since the latter is usually abnormal from birth in the mucopolysaccharidoses even when total GAG excretion as hexuronic acid is within normal limits, and well before radiological changes are demonstrable (Pennock, 1973) .
In conclusion, the methods outlined in the appendix are adequate for the diagnosis of the various mucopolysaccharidoses provided note is taken of the difficulties which may be encountered and which have been discussed in the preceding paragraphs. The methods are simple and require the minimum of apparatus and technical skill and should, therefore, be easily performed in any hospital or laboratory. They will remain of value in the investigation of the mucopolysaccharidoses until such time as suitable enzyme substrates are made available commercially. More specialized or new methods are required for the study of keratan sulphate excretion and the identification of patients with Morquio's disease.
I am indebted to Dr G. Walters for helpful advice during the preparation of this review. Early morning specimens should not be used for screening tests, and infected samples collected at any time are unsuitable for analysis. Either single specimens passed between 0900 and 1800 hours or complete 24-hour specimens should be collected without preservative and stored frozen until analysed. (Freezing is not absolutely essential provided the sample does not become secondarily infected.)
The specific gravity of the sample should be measured and adjusted to less than 1 020 with distilled water if necessary. The sample should be centrifuged and the supernatant used for the estimation of creatinine and for the following tests. 'Results higher than this may be found in normal infants in the first 2 weeks of life.
higher percentage of false positive results at this age than is usually found later in life (see text).
C. QUANTITATIVE ESTIMATION OF GAG BY MEASUREMENT OF HEXURONIC ACID

CONTENT
Principle
All the glycosaminoglycans, except keratan sulphate, contain hexuronic acids as part of the molecule. This will react with carbazole in the presence of concentrated sulphuric acid to give a magenta coloured product. The GAGs must first be isolated from other hexuronic acid-containing metabolites, and this is simply achieved by using CPC as precipitant.
Reagents
The following reagents are used for isolation of GAG (Di Ferrante, 1967) and estimation of hexuronic acid (Bitter and Muir, 1962 5-6 years 20-7 12-0 6-7 years 16 5 9-6 7-9 years 13-6 7-9 9-10 years 11-3 6-6 10-11 years 10-3 6-0 11-19 years 9-1 5.3
Adults 6-2 3-6 Table H Upper limit of normal range for GAG hexuronic acid in relation to creatinine at different ages (Pennock et al, 1971 and (Humbel and Chamoles, 1972) This method is based on the differences in solubility of the calcium salts of GAG in different concentrations of alcohol. The thin layer plate is chromatographed through six separate solutions of decreasing alcohol concentration. Cellulose plates 01 mm thick, 20 x 20 cm (Polygram CEL 300 Camblab, Cambridge), are marked with a soft pencil at 2 cm distances from the bottom of the plate. Approximately 10 ,il of GAG solution is applied on the first line in a thin streak, 1-2 cm in width, and dried. The plate is then placed in the first solvent and this is allowed to ascend to the second line. The The first solution has a slightly higher concentration of alcohol than that used by Humbel and Chamoles (1972) and affords a better separation of KS. The solvents must be prepared fresh for each separation.
After the chromatography is complete the plate is dried and stained for 10 minutes in 1 % alcian blue 8GX in 7000 ethanol-acetic acid mixture (95/5/v/v). The plate is washed with 10% acetic acid to remove as much excess dye as possible.
If the individual solvent fronts are numbered 1 to 6 from the origin, the migration position of different GAG in relation to these fronts is as follows: DS(1-2), HS(2-3), C4S(4), C6S(4-5), and KS(5-6).
Interpretation is easier than with electrophoresis. 
